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ABSTRACT
Objective: To investigate the hepatoprotective activity of aqueous methanolic extract of polyherbal formulation and individual extracts of Calotropis 
procera, Gymnema sylvestre, and Lawsonia inermis leaves.
Methods: The hepatoprotective activity of the formulation and extracts were assessed on the basis of histopathological changes in liver of carbon 
tetrachloride-induced hepatotoxic rats.
Results: The result of present studies strongly indicates that the hepatoprotective property of polyherbal formulation as evidenced by less damaged 
hepatocytes cells.
Conclusion: Polyherbal formulation revealed excellent hepatoprotective profile as compared to individual plants due to synergistic effect produced 
by different phytochemicals present in the formulation.
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INTRODUCTION
Liver diseases have turned into a global concern worldwide. The 
primary causative variable is increasing alcohol consumption, anemia, 
disease, malnutrition, iron deficiency, and accessibility of hepatotoxic 
medications over the counter. Treatment choices for normal liver 
diseases, for example, cirrhosis, chronic hepatitis, and fatty liver are 
dangerous. The routine medications utilized as a part of the treatment 
of liver illnesses, viz., corticosteroids, antiviral, and immunosuppressant 
drugs are once in a while deficient and may prompt genuine antagonistic 
impacts. Incomprehensibly, these may themselves bring about hepatic 
harm [1].
Calotropis procera (Ait) R.Br. belongs to family Asclepiadaceae, locally 
known as “Madar” [2]. C. procera is one of the most popular medicinal 
herbs in India [3]. Different parts of the plant have been used as 
anthelmintic, purgative and in diseases such as ulcer and leprosy. The 
latex of this plant possess antidiarheal [4], antidiabetic [5], anticancer 
properties [6], and antipyretic analgesic [7]. The root extract is reported 
to have antitumor [8], anti-inflammatory, and analgesic effects [9]. 
The stem bark possesses antifungal property [10]. In view of these 
observations, the C. procera has established a good deal of interest from 
pharmacological interest.
Gymnema sylvestre R. Br. belongs to the family Asclepiadaceae [11]. 
In India, it is known as “gur-mar” or “sugar destroyer” because 
the leaves of this plant have antidiabetic activity [12]. It is used in 
folk, Ayurvedic, and Homeopathic Systems of Medicine. G. sylvestre 
leaves have gymnemic acids, which is important in balancing insulin 
levels and lowering blood sugar [13]. It is reported to possess 
antihypercholesterolemic, antimicrobial, antiallergic, hepatoprotective, 
antiviral [14], hypoglycemic, hypolipidemic [15] diuretic [16], and 
anticancerproperties [17].
Lawsonia inermis Linn. is commonly known as “henna.” This plant has 
been used for the treatment of epilepsy and for malignant ulcer. Henna 
reduced both hyperglycemia and inflammation significantly [18]. 
Moreover, the leaves are used as hepatoprotective, antioxidant, 
bronchitis, headache, ophthalmia, syphilitics, amenorrhea, scabies, and 
also in hair growth [19-25].
In third world countries including India, up to 90% of the populace still 
relies entirely on plants as a resource of medicines [26]. Due to lack of 
a consistent liver protective medicine in the modern system, a number 
of medicinal preparations in Ayurveda, the Indian system of medicine, 
are recommended for the cure of liver disorders. Natural remedies 
from medicinal plants are considered to be effective and safe option 
medicines for hepatotoxicity. Carbon tetrachloride (CCl4)-induced 
hepatic injury is one of the most investigated animal models and in the 
past decades, molecular mechanisms for hepatic necrosis, and steatosis 
induced by CCl4 were well prominent. It is assumed that the effect of 
G. sylvestre, C. procera, and L. inermis extracts on liver protection is 
related to free radical suppressing activity. This study deals with the 
comparison of hepatoprotective activity of herbal formulation against 
individual extracts. Therefore, in this try out, we report the comparative 
hepatoprotective effects of formulation and individual extracts against 
CCl4-induced hepatic injury.
METHODS
Collection and authentication of plant materials
The leaves of C. procera, G. sylvestre, and L. inermis were collected from 
Herbal Garden of Hygia Institute of Pharmaceutical Education and 
Research, Lucknow, Uttar Pradesh, India, in the month of January and 
February and identified at the NISCAIR Delhi and CIMAP, Lucknow. 
Voucher specimens (1144/176, GS-1, LI-1) has been deposited for 
further future reference.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Preparation of crude extracts and polyherbal formulation
Fresh leaves of C. procera, G. sylvestre, and L. inermis were collected, cleaned 
and dried under shade. Herbal ingredients were powdered separately and 
stored. Polyherbal preparation was made by mixing the three ingredients 
in equal ratio (w/w) and homogenizing in aqueous methanol (30:70) 
with the help of a pestle and mortar [27]. Polyherbal formulation and 
crude extracts were macerated with aqueous methanol (30:70) for 
7 days in airtight vessels with occasional shaking at room temperature. 
Then filtration was done with Whatman filter paper No. 1. The filtrates 
were concentrated under reduced pressure in rotary evaporator. The 
formulation and crude extracts were stored in airtight container.
Phytochemical studies
All extracts were subjected for phytochemical psychoanalysis to 
determine the presence of alkaloids, glycosides, saponins, steroids, 
proteins, polysaccharides, and tannins [28].
Evaluation of hepatoprotective activity
Experiment animals
Albino Wistar rats were used in this study. The project was approved 
by the Institution Animal Ethical Committee (1088/PO/Re/S/2007/
CPCSEA). The animals were kept at 27±2°C with relative humidity 
44-46% and light and dark cycles of 10 and 14 hrs, respectively, for 
1 week before and during experiments. Animals were provided with 
standard diet (Lipton, India) and water ad libitium. Food was withdrawn 
18-24 hrs before the start of the experiment. All the experiments were 
performed in the morning according to current course of action for the 
care of the Laboratory Animals and the Ethics Guidelines.
Acute toxicity studies
The acute toxicity studies for the formulation and extracts of G. sylvestre, 
C. procera, and L. inermis were performed earlier using OECD 423 
guideline [27].
Screening method
Rats were divided into seven groups of six animal each (n=6). Group I 
(control) animals were administered a single dose of water (1 ml/kg, p.o.) 
daily for 5 days and received liquid paraffin (1:1, 2 ml/kg, s.c.) on day 
2 and 3. Group II (CCl4) received water (1 ml/kg body weight, p.o.) 
once daily for 5 days and received CCl4:liquid paraffin (1:1, 2 ml/kg 
body weight, s.c.) on day 2 and 3. Group III received standard drug 
silymarin (100 mg/kg, p.o.) once daily for 5 days. Test groups animals 
(Groups IV-VII) were administered orally a dose of 200 mg/kg of 
polyherbal formulation, G. sylvestre, C. procera, and L. inermis extracts, 
respectively, in the form of aqueous suspension once daily. The 
Groups III-VII animals were administered in tandem CCl4:liquid 
paraffin (1:1, 2 ml/kg body weight, s.c.) on day 2 and 3 after 30 min of 
administration of the silymarin and extracts [29].
Estimation of biochemical markers
Biochemical parameters such as serum glutamic oxaloacetic 
transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), 
serum alkaline phosphatase (ALP), and total bilirubin, cholesterol were 
analyzed and reported previously [27].
Histopathological studies
The animals from all the groups were sacrificed using euthanasia 
24 hrs after CCl4 administration. The liver was dissected out and used 
for histopathological studies [30]. Briefly liver was sliced and pieces 
were preserved in 10% formalin for proper fixation. These tissues were 
processed and embedded in paraffin wax. Section of 5-6 µ in thickness 
was cut and stained with hematoxylin and eosin. All the sections of 
the tissues were examined under microscope for analyzing the altered 
architecture in the liver tissue due to CCl4 challenge and improved liver 
architecture due to pretreatment with test extracts and standard drug 
which was documented by taking images using microscope.
Histopathological findings
The severity of the liver morphological changes induced by CCl4 
treatment was summarized. Our results showed that administration 
of silymarin greatly improved liver morphological changes, fibrosis, 
and necrosis. The liver sections of the rats from control group had 
normal hepatic cells with well-preserved cytoplasm, central vein, 
and prominent nucleolus (Fig. 1a). Severe histopathological changes 
Fig. 1: Sections stained with hematoxylin and eosin (×400) displaying the liver sections of rats treated with, (a) Control group, 
(b) carbon tetrachloride (CCl4) group, (c) standard group, (d) polyherbal formulation, (e) Gymnema sylvestre, (f) Calotropis procera, and 
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were observed in livers of all the rats from CCl4-treated animals. 
In CCl4 treated animals, the sections showed sever degree of liver 
damage, such as necrosis, hydropic degeneration, and infiltration 
of inflammatory cells (Fig. 1b). The histological appearance of the 
silymarin group was quite similar to that of the control group (Fig. 1c). 
In polyherbal formulation (200 mg/kg, p.o.) treated animals, liver 
section showing clearly less than those groups that received CCl4 
only. The livers of the rats in this group showed occasional dysplastic 
hepatocytes and apoptotic cells, most of which were not abnormal and 
no extensive necrotic, and hydropic degeneration changes were seen 
in livers (Fig. 1d). In G. sylvestre (200 mg/kg, p.o.) treated animals, the 
liver sections showed mild inflammation, but overall picture resembles 
normal liver (Fig. 1e).
Treatment with C. procera (200 mg/kg, p.o.) showed moderate 
inflammation and congestion, however, only a few lobules of livers 
showed a focus of degenerative cells, most of which had the normal 
nuclear appearance and mild cytoplasmic degeneration (Fig. 1f). 
Treatment with L. inermis (200 mg/kg, p.o.) showed moderate 
inflammation and congestion (Fig. 1g). Morphological findings in 
all groups of this study were consistent with observations of serum 
enzymes such as SGPT, SGOT, ALP, cholesterol, and tuberculosis values 
as reported previously [27].
RESULTS AND DISCUSSION
The liver can be injured by various chemicals and drugs. In this 
study, CCl4 was selected as a hepatotoxicant to induced liver damage. 
The primary goal of this study is to assess the comparison studies 
of hepatoprotective activity between herbal formulation and 
individual extract of various plants against chronic liver damage. 
Histopathological changes such as sever macrovesicular, congestion, 
and microvesicular steatosis were observed in CCl4 treated groups. All 
extracts prevented these histopathological changes, further indicating 
their hepatoprotective activity.
From the results, the hepatoprotective activity of the extracts were in the 
order of Group III received standard drug silymarin (100 mg/kg, p.o.) > 
Groups IV received polyherbal formulation extracts (200 mg/kg, p.o.) > 
Groups V received G. sylvestre extracts (200 mg/kg, p.o.) > Groups VI 
received C. procera extracts (200 mg/kg, p.o.) > Groups VII received 
L. inermis extracts (200 mg/kg, p.o.). Phytoconstituents such as phenolic 
compounds and tannins were reported for their hepatoprotective 
effects [27] and these two were present in alcoholic and aqueous 
extracts. These active principles may be accounted for hepatoprotective 
effect. In summary, this study demonstrates that polyherbal formulation 
had a protective effect against CCl4-induced acute hepatic damage in 
rats. The hepatoprotective effect of polyherbal formulation is expected 
due to its ability to the inflammatory responses, in combination with 
the ability to scavenge free radicals.
CONCLUSION
The result of this study clearly demonstrates that the histopathological 
alterations produced by CCl4 in tissue were significantly reserved by 
the pretreatment of extracts of polyherbal formulation, crude extracts, 
and Silymarin. In conclusion, the polyherbal formulation showed good 
hepatoprotective effect as compared to the individual extracts against 
CCl4-induced hepatotoxicity in albino rats. This study confirms its use 
as hepatoprotective as per the ethno pharmacological claims.
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